ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

Evaluating Second-Line Treatment Options in Bladder Cancer

Daniel P. Petrylak, MD
Published Online:1:16 PM, Fri December 16, 2016

Daniel P. Petrylak, MD, professor of Medicine and Urology, Yale Cancer Center, discusses studies evaluating second-line treatment options in bladder cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.